Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RAu0zXQmdIOBMsbzHUdw8m67u3NCf_7rN9XGe3NL7QS38#assertion>. }
Showing items 1 to 9 of
9
with 100 items per page.
- association type Statement assertion.
- association label ""Physostigmine Salicylate Injection should not be used in the presence of asthma, gangrene, diabetes, cardiovascular disease, mechanical obstruction of the intestine or urogenital tract or any vagotonic state, and in patients receiving choline esters and depolarizing neuromuscular blocking agents (decamethonium, succinylcholine). For post-anesthesia, the concomitant use of atropine with physostigmine salicylate is not recommended, since the atropine antagonizes the action of physostigmine."" assertion.
- association object DOID_2841 assertion.
- association predicate treats assertion.
- association subject drugbank:DB00981 assertion.
- association relation MedicalContraindication assertion.
- drugbank:DB00981 category Drug assertion.
- DOID_2841 category Disease assertion.
- association provided_by NeuroDKG assertion.